Reaction Details |
| Report a problem with these data |
Target | Adenosine receptor A2b |
---|
Ligand | BDBM551718 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Measurement of A2A and A2B Antagonism in cAMP Cell-Based Assay |
---|
IC50 | 4.50±n/a nM |
---|
Citation | Larsen, MA; Ali, A; Cumming, J; DeMong, D; Deng, Q; Graham, TH; Hennessy, E; Hoover, AJ; Liu, P; Liu, K; Mansoor, UF; Pan, J; Plummer, CW; Sather, A; Swaminathan, U; Wang, H; Zhang, Y 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use US Patent US11312719 Publication Date 4/26/2022 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Adenosine receptor A2b |
---|
Name: | Adenosine receptor A2b |
Synonyms: | AA2BR_HUMAN | ADENOSINE A2B | ADORA2B | Adenosine receptor A2B (A2B) | Adenosine receptors A2b | Adenosine receptors; A2a & A2b |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 36341.22 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 332 |
Sequence: | MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLAAADVAVGLFA
IPFAITISLGFCTDFYGCLFLACFVLVLTQSSIFSLLAVAVDRYLAICVPLRYKSLVTGT
RARGVIAVLWVLAFGIGLTPFLGWNSKDSATNNCTEPWDGTTNESCCLVKCLFENVVPMS
YMVYFNFFGCVLPPLLIMLVIYIKIFLVACRQLQRTELMDHSRTTLQREIHAAKSLAMIV
GIFALCWLPVHAVNCVTLFQPAQGKNKPKWAMNMAILLSHANSVVNPIVYAYRNRDFRYT
FHKIISRYLLCQADVKSGNGQAGVQPALGVGL
|
|
|
BDBM551718 |
---|
n/a |
---|
Name | BDBM551718 |
Synonyms: | (R or S)-3-(4-((2S,5R or 2R,5S)-5-(5-amino-9-fluoro-8-methoxy- [1,2,4]triazolo[1,5-c]quinazolin-2-yl)-2-methylpiperidin-1-yl)- 1H-pyrazol-1-yl)-3-methylbutan-2-ol | US11312719, Example 264 | US11312719, Example 265 | US11312719, Example 266 | US11312719, Example 267 |
Type | Small organic molecule |
Emp. Form. | C24H31FN8O2 |
Mol. Mass. | 482.5537 |
SMILES | COc1cc2nc(N)n3nc(nc3c2cc1F)C1CCC(C)N(C1)c1cnn(c1)C(C)(C)C(C)O |
Structure |
|